Treating relapsed and refractory metastatic germ cell tumours with high-dose chemotherapy with carboplatin and etoposide and autologous haematopoietic stem cell transplantation.
İsmail ErtürkNuri KaradurmusHalil KızılozRamazan AcarBirol YildizMusa Baris AykanRamazan EsenGalip BuyukturanYuksel UrunGokhan ErdemFikret ArpacıPublished in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2020)
This sizeable single-centre study shows that patients with relapsed metastatic GCT are curable by CE as high dose chemotherapy plus AHSCT with reliable toxicity even for a single cycle.
Keyphrases
- high dose
- stem cell transplantation
- germ cell
- low dose
- acute lymphoblastic leukemia
- acute myeloid leukemia
- squamous cell carcinoma
- small cell lung cancer
- multiple myeloma
- hodgkin lymphoma
- diffuse large b cell lymphoma
- locally advanced
- bone marrow
- phase ii study
- cell therapy
- stem cells
- clinical trial
- chemotherapy induced
- mesenchymal stem cells